Physician

Mona L Camacci, MD

According to 2025 Medicare claims, Mona Camacci, MD (NPI: 1669900114) practices ophthalmology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29910-4883.

Camacci's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,096 traditional Medicare patients, billed 29,951 HCPCS/CPT codes, and received $3,764,134 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 687 prescription claims across 166 beneficiaries totaling $18,274 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 36 records totaling $34,057. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,999 and ending at $18,274. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2021 Medicare payment: $6,812 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $9,099 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,149,068 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,764,134 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20214886$6,812
202299138$9,099
202354213,068$1,149,068
20241,09629,951$3,764,134

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$33K$67K2017 Drug cost: $1,999 (USD; Tot_Drug_Cst)2018 Drug cost: $15,225 (USD; Tot_Drug_Cst)2019 Drug cost: $66,524 (USD; Tot_Drug_Cst)2020 Drug cost: $57,488 (USD; Tot_Drug_Cst)2021 Drug cost: $12,975 (USD; Tot_Drug_Cst)2022 Drug cost: $20,452 (USD; Tot_Drug_Cst)2023 Drug cost: $11,055 (USD; Tot_Drug_Cst)2024 Drug cost: $18,274 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171421$1,999
201873139$15,225
2019152495$66,524
2020123348$57,488
202182182$12,975
2022138434$20,452
2023127333$11,055
2024166687$18,274

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3621,897$85
92014Established patient complete exam of visual system617799$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5561,190$65
92134Imaging of retina5322,107$28
92250Photography of the retina8101,481$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate843,668$4,566
Atropine SulfateAtropine Sulfate812,704$2,543
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1723,617$2,102
Timolol MaleateTimolol Maleate201,154$1,781
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat815,638$1,195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$8,257Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.2$25,800Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mona L. Camacci, MD?

Tedicare shows public-source Medicare data for Mona L. Camacci, MD (NPI 1669900114), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mona L. Camacci, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mona L. Camacci, MD?

Mona L. Camacci, MD is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does Mona L. Camacci, MD have Open Payments data?

Mona L. Camacci, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.